Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Qiagen GmbH
Qiagen GmbH
Activities:
Manufacturing
Research & Development
Analysis
Medical Devices
X
LinkedIn
Trending Articles
Neopac showcases latest tube, dispensing and cap innovations at Pharmapack Paris
Highlights include company’s reduced material LowPro caps and world’s smallest child resistant tube
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Indian government bans three medicines owing to health risks
Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
You need to be a subscriber to read this article.
Click here
to find out more.
Parenteral preparations: formulation challenges
Parenteral preparations are defined as solutions, suspensions, emulsions for injection or infusion, powders for injection or infusion, gels for injection and implants. They are...
Lonza’s capsule delivers acid-sensitive ingredients to the intestine
The capsule can simplify the manufacturing process to accelerate drug development and expedite first-in-human timelines
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Finance
Qiagen introduces cloud-based product selection application
The Workflow Configurator allows customers to choose from a variety of products per workflow step, as well as save, share and purchase their bespoke product configuration
Manufacturing
Tecan and Qiagen collaborate on automation in blood analysis
The device is aimed to reduce the risk of operators coming into contact with infectious materials and save time
Research & Development
Qiagen enters agreement with precision diagnostics company
The German company has received an exclusive license to use Ares Genetics’s database and toolbox, to develop bioinformatics and assays for antimicrobial resistance research
Analysis
Qiagen invests in Digital PCR machines
Fully integrated Digital PCR machines will be in use by 2020 at Qiagen
Media
Protein purification and isolation market worth US$6370m by 2020
The market is growing due to increased R&D, as well as demand for ligand ID and rapid purification kits
Ingredients
Qiagen acquires Enzyme Solutions Unit of Enzymatics
Now able to offer a complete next-generation sequencing workflow from biological sample to molecular insights
You need to be a subscriber to read this article.
Click here
to find out more.
Regulatory
Reimbursment issues hinder future development of personal therapies
The development of more targeted therapies is moving apace, but are the payers prepared for it? Dr Sarah Houlton looks at the progress of personalised medicines
Subscribe now